Eye Journal Citation Rate 2026

ISSN 0950-222X eISSN 1476-5454 Springer Nature GB

Q2 Quartile Established Impact

About Eye
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Eye (E) is a peer-reviewed academic journal covering Glaucoma and retinal disorders and Intraocular Surgery and Lenses, published by Springer Nature in GB, catalogued under ISSN 0950-222X (e-ISSN 1476-5454). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.59 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4990 USD). OpenAlex records 14,835 works and 303,983 citations, with an h-index of 169.

Eye Citation Rate 2026 — In Context

Eye has a 2025 2-Year Citation Rate (OpenAlex) of 2.59, placing it in the Q2 quartile within the Glaucoma and retinal disorders research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Eye operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Eye should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Eye against similar journals in the field, use our journal comparison tool.

Submission Tips for Eye
  • Budget $4990 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Glaucoma and retinal disorders, Intraocular Surgery and Lenses, Ophthalmology and Visual Impairment Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Eye Compares
Citation Rate vs Field Avg
+39%
Field avg: 1.86
APC vs Field Avg
+42%
Field avg: $3513

Compared against 18 journals in the same research areas.

ISSN (Print) 0950-222X
ISSN (Online) 1476-5454
Publisher Springer Nature
Country United Kingdom
APC / Cost $4990 USD
h-index 170
Total Works 14,941
Total Citations 306,400
2-yr Mean Citedness 2.89 (OpenAlex)
In-depth profile & metrics

Eye is published by Springer Nature and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4990.

In our subject taxonomy, Eye is classified under Glaucoma and retinal disorders, Intraocular Surgery and Lenses, Ophthalmology and Visual Impairment Studies and Retinal Diseases and Treatments.

Eye is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 14,941 works that have together drawn 306,400 citations, giving the journal an h-index of 170; its most recent citation rate stands at 2.594; OpenAlex puts its two-year mean citedness at 2.89.

Research Areas
Links
Frequently Asked Questions about Eye

Eye does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.594 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Eye is not an open access journal.

The Article Processing Charge (APC) for Eye is $4990 USD.

Eye is published by Springer Nature.

Eye shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Eye is 0950-222X. Its electronic ISSN (eISSN) is 1476-5454.

Eye sits in the Q2 quartile based on its latest impact factor of 2.59, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.594
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.594 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 630 1,207
2024 659 4,279
2023 517 5,061
2022 523 6,179
2021 523 8,929
2020 596 12,334
2019 434 9,227
2018 348 10,381
2017 337 8,753
2016 320 10,007
2015 307 9,246
2014 334 9,459
Journal at a Glance
14,941
Total Works
306,400
Total Citations
170
h-index
2.89
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Eye most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

2,981 works
2,892 works
2,193 works
1,989 works
1,595 works
1,330 works

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S167047176

Get weekly updates for Glaucoma and retinal disorders journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google